281 related articles for article (PubMed ID: 33664168)
1. COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications.
Memar Montazerin S; Najafi H; Shojaei F; Chi G; Goudarzi S; Sharfaei S; Kahe F; Hassanzadeh S
Infez Med; 2021 Mar; 29(1):1-9. PubMed ID: 33664168
[TBL] [Abstract][Full Text] [Related]
2. The Impact of COVID-19 Disease on Platelets and Coagulation.
Wool GD; Miller JL
Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
[TBL] [Abstract][Full Text] [Related]
3. Covid-19-induced coagulopathy and observed benefits with anticoagulation.
Karimzadeh S; Dong V; Hassan OG; Raut A; Fouda A; Parrill A; Eaton K; Huy NT
Transfus Apher Sci; 2020 Dec; 59(6):102906. PubMed ID: 32778522
[No Abstract] [Full Text] [Related]
4. COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation.
Salabei JK; Fishman TJ; Asnake ZT; Ali A; Iyer UG
Heart Lung; 2021; 50(2):357-360. PubMed ID: 33524866
[TBL] [Abstract][Full Text] [Related]
5. Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.
Abdel-Bakky MS; Amin E; Ewees MG; Mahmoud NI; Mohammed HA; Altowayan WM; Abdellatif AAH
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215822
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment and prognostic aspect of coagulopathy in COVID-19.
Rahman M; Rakhi NN
Adv Respir Med; 2021; 89(1):90-91. PubMed ID: 33559122
[TBL] [Abstract][Full Text] [Related]
7. Complement activation and coagulopathy - an ominous duo in COVID19.
Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Coagulopathy: From Pathogenesis to Treatment.
Alnima T; Mulder MMG; van Bussel BCT; Ten Cate H
Acta Haematol; 2022; 145(3):282-296. PubMed ID: 35499460
[TBL] [Abstract][Full Text] [Related]
9. Haematological manifestations of COVID-19: From cytopenia to coagulopathy.
Agbuduwe C; Basu S
Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356
[TBL] [Abstract][Full Text] [Related]
10. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
Eljilany I; Elzouki AN
Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
[TBL] [Abstract][Full Text] [Related]
11. [Peculiarities of blood coagulation disorders in patients with COVID-19].
Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 versus HIT hypercoagulability.
Warkentin TE; Kaatz S
Thromb Res; 2020 Dec; 196():38-51. PubMed ID: 32841919
[TBL] [Abstract][Full Text] [Related]
14. [COVID-19: Coagulopathy and thrombosis].
Tazi Mezalek Z
Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
[TBL] [Abstract][Full Text] [Related]
15. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II.
Favaloro EJ; Lippi G
Semin Thromb Hemost; 2021 Jun; 47(4):333-337. PubMed ID: 34062596
[No Abstract] [Full Text] [Related]
16. Viscoelastic Tests in the Evaluation of Haemostasis Disturbances in SARS-CoV2 Infection.
Rodrigues A; Seara Sevivas T; Leal Pereira C; Caiado A; Robalo Nunes A
Acta Med Port; 2021 Jan; 34(1):44-55. PubMed ID: 33159728
[TBL] [Abstract][Full Text] [Related]
17. Coronavirus Disease 2019: Hematological Anomalies and Antithrombotic Therapy.
Ornelas-Ricardo D; Jaloma-Cruz AR
Tohoku J Exp Med; 2020 Aug; 251(4):327-336. PubMed ID: 32788506
[TBL] [Abstract][Full Text] [Related]
18. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.
Hardy M; Michaux I; Lessire S; Douxfils J; Dogné JM; Bareille M; Horlait G; Bulpa P; Chapelle C; Laporte S; Testa S; Jacqmin H; Lecompte T; Dive A; Mullier F
Thromb Res; 2021 Jan; 197():20-23. PubMed ID: 33161283
[No Abstract] [Full Text] [Related]
19. Coagulopathy in COVID-19: Manifestations and management.
Mucha SR; Dugar S; McCrae K; Joseph D; Bartholomew J; Sacha GL; Militello M
Cleve Clin J Med; 2020 Jul; 87(8):461-468. PubMed ID: 32409435
[TBL] [Abstract][Full Text] [Related]
20. [COVID-19-associated coagulopathy].
Morishita E
Rinsho Ketsueki; 2021; 62(8):1236-1246. PubMed ID: 34497212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
